Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleRADIOPHARMACY

Parathyroid Imaging: The Importance of Dual-Radiopharmaceutical Simultaneous Acquisition with 99mTc-Sestamibi and 123I

Scott A. Caveny, William C. Klingensmith, Wesley E. Martin, Adrienne Sage-El, Robert C. McIntyre, Christopher Raeburn and Pamela Wolfe
Journal of Nuclear Medicine Technology June 2012, 40 (2) 104-110; DOI: https://doi.org/10.2967/jnmt.111.098400
Scott A. Caveny
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William C. Klingensmith III
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wesley E. Martin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne Sage-El
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert C. McIntyre Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Raeburn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamela Wolfe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Example of single-tracer, dual-phase protocol. Pinhole images of neck were obtained in anterior (ANT), right anterior oblique (RAO), and left anterior oblique (LAO) projections at 15 min and 3 h after intravenous injection of 99mTc-sestamibi. In addition, parallel-hole collimator image from submandibular salivary glands to left ventricle was obtained in anterior projection at 15 min and 3 h (not shown). There is subtle suggestion of adenoma at upper pole of left lobe of thyroid at both 15 min and 3 h. 99mTc-sestamibi washes out of parathyroid adenoma in a manner similar to the way it washes out of thyroid.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Example of double-tracer, single-phase protocol from same patient as shown in Figure 1. 123I was given orally 2 h before intravenous administration of 99mTc-sestamibi. Simultaneous pinhole images of 99mTc-sestamibi and 123I were acquired of neck in anterior (ANT), right anterior oblique (RAO), and left anterior oblique (LAO) projections at 15 min after administration of 99mTc-sestamibi. In addition, simultaneous parallel-hole image of 99mTc-sestamibi and 123I from submandibular glands to left ventricle was obtained in anterior projection at 15 min (not shown). Parathyroid adenoma is clearly seen at upper pole of left lobe of thyroid in subtraction images.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Example of double-tracer, double-phase protocol from same patient as shown in Figure 1. In addition to simultaneously acquired 99mTc-sestamibi and 123I images at 15 min shown in Figure 2, same images were acquired again at 3 h. 99mTc-sestamibi washes out of parathyroid adenoma at same rate as it washes out of thyroid gland. ANT = anterior; RAO = right anterior oblique; LAO = left anterior oblique.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Performance of each of 3 protocols is shown for correctly localizing position of 41 parathyroid adenomas in 37 patients. Data represent average results for 2 readers. ST-DP = single-tracer, dual-phase, DT-SP = dual-tracer, single-phase, DT-DP = dual-tracer, dual-phase.

Tables

  • Figures
    • View popup
    TABLE 1

    Grading Results for Each of 3 Protocols for 41 Adenomas in 37 Patients

    Degree of certainty of location
    ProtocolReader0123
    ST-DPA177116
    B98 (1)8 (1)16
    DT-SPA1101119
    B411521
    DT-DPA310919
    B56921
    • 0 = no adenoma seen; 1 = possible adenoma; 2 = probable adenoma; 3 = definite adenoma; ST-DP = single-tracer, dual-phase; DT-SP = dual-tracer, single-phase; DT-DP = dual-tracer, dual-phase.

    • Numbers in parentheses indicate numbers of localizations that were incorrect.

    • View popup
    TABLE 2

    Localization Success for Each of 3 Protocols

    Localization success
    ProtocolReaderAdenomasCorrect95% CI
    ST-DPA24/4159%42–74
    B30/4173%57–86
    DT-SPA40/4198%87–100
    B37/4190%77–97
    DT-DPA38/4192%80–98
    B36/4188%74–96
    • CI = exact binomial confidence interval; ST-DP = single-tracer, dual-phase; DT-SP = dual-tracer, single-phase; DT-DP = dual-tracer, dual-phase.

    • Calculations are on per-adenoma basis. There were 41 adenomas in 37 patients.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 40 (2)
Journal of Nuclear Medicine Technology
Vol. 40, Issue 2
June 1, 2012
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Parathyroid Imaging: The Importance of Dual-Radiopharmaceutical Simultaneous Acquisition with 99mTc-Sestamibi and 123I
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Parathyroid Imaging: The Importance of Dual-Radiopharmaceutical Simultaneous Acquisition with 99mTc-Sestamibi and 123I
Scott A. Caveny, William C. Klingensmith, Wesley E. Martin, Adrienne Sage-El, Robert C. McIntyre, Christopher Raeburn, Pamela Wolfe
Journal of Nuclear Medicine Technology Jun 2012, 40 (2) 104-110; DOI: 10.2967/jnmt.111.098400

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Parathyroid Imaging: The Importance of Dual-Radiopharmaceutical Simultaneous Acquisition with 99mTc-Sestamibi and 123I
Scott A. Caveny, William C. Klingensmith, Wesley E. Martin, Adrienne Sage-El, Robert C. McIntyre, Christopher Raeburn, Pamela Wolfe
Journal of Nuclear Medicine Technology Jun 2012, 40 (2) 104-110; DOI: 10.2967/jnmt.111.098400
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Primary Hyperparathyroidism: Defining the Appropriate Preoperative Imaging Algorithm
  • Parathyroid Imaging with Simultaneous Acquisition of 99mTc-Sestamibi and 123I: The Relative Merits of Pinhole Collimation and SPECT/CT
  • The Role of Radionuclide Imaging in the Surgical Management of Primary Hyperparathyroidism
  • Preoperative imaging for focused parathyroidectomy: making a good strategy even better
  • Parathyroid Imaging: The Importance of Pinhole Collimation with Both Single- and Dual-Tracer Acquisition
  • Google Scholar

More in this TOC Section

  • Miniaturized Radiochemical Purity Testing for 99mTc-HMPAO, 99mTc-HMDP, and 99mTc-Tetrofosmin
  • Changes in Patterns of 99mTc-Macroaggregated Albumin Use Between 2000 and 2015
  • Absorbed Radiation Doses to Staff After Implementation of a Radiopharmacy Clean Room
Show more Radiopharmacy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire